DE60330780D1 - Sequenzen des t-zellrezeptors cdr3 und nachweisverfahren - Google Patents
Sequenzen des t-zellrezeptors cdr3 und nachweisverfahrenInfo
- Publication number
- DE60330780D1 DE60330780D1 DE60330780T DE60330780T DE60330780D1 DE 60330780 D1 DE60330780 D1 DE 60330780D1 DE 60330780 T DE60330780 T DE 60330780T DE 60330780 T DE60330780 T DE 60330780T DE 60330780 D1 DE60330780 D1 DE 60330780D1
- Authority
- DE
- Germany
- Prior art keywords
- sequences
- detection method
- cell receptor
- disclosed
- receptor cdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108091008874 T cell receptors Proteins 0.000 title abstract 3
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 title abstract 3
- 238000001514 detection method Methods 0.000 title 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 3
- 208000023275 Autoimmune disease Diseases 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Wood Science & Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38628702P | 2002-06-05 | 2002-06-05 | |
| PCT/US2003/017873 WO2003104407A2 (en) | 2002-06-05 | 2003-06-05 | T cell receptor cdr3 sequences and methods for detection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60330780D1 true DE60330780D1 (de) | 2010-02-11 |
Family
ID=29736145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60330780T Expired - Lifetime DE60330780D1 (de) | 2002-06-05 | 2003-06-05 | Sequenzen des t-zellrezeptors cdr3 und nachweisverfahren |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1530483B1 (enExample) |
| JP (3) | JP2005528910A (enExample) |
| CN (1) | CN1674931A (enExample) |
| AT (1) | ATE453727T1 (enExample) |
| AU (1) | AU2003237437B2 (enExample) |
| BR (1) | BR0311578A (enExample) |
| CA (1) | CA2485874A1 (enExample) |
| DE (1) | DE60330780D1 (enExample) |
| IL (2) | IL165194A (enExample) |
| MX (1) | MXPA04011646A (enExample) |
| NO (1) | NO20044945L (enExample) |
| NZ (1) | NZ537403A (enExample) |
| PL (1) | PL213315B1 (enExample) |
| RU (1) | RU2004139045A (enExample) |
| WO (1) | WO2003104407A2 (enExample) |
| ZA (1) | ZA200409792B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2018160T3 (da) | 2006-03-16 | 2012-02-06 | Tris Pharma Inc | Modificeret depotformuleringer indeholdende lægemiddel-ionbytterharpikskomplekser |
| CA2880456A1 (en) | 2012-08-15 | 2014-02-20 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
| US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
| CN108070644B (zh) * | 2016-11-08 | 2021-06-29 | 国家卫生计生委科学技术研究所 | 一种妊娠高血压的诊断系统 |
| TWI786096B (zh) | 2017-03-15 | 2022-12-11 | 學校法人兵庫醫科大學 | 癌症免疫療法之新穎生物標記 |
| US12458592B1 (en) | 2017-09-24 | 2025-11-04 | Tris Pharma, Inc. | Extended release amphetamine tablets |
| US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL97709A (en) * | 1990-03-30 | 2005-05-17 | Brigham & Womens Hospital | Use of an mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis |
| ATE486956T1 (de) * | 1999-02-23 | 2010-11-15 | Baylor College Medicine | T-zellrezeptor vb-db-jb-sequenz und verfahren für ihren nachweis |
-
2003
- 2003-06-05 EP EP03736888A patent/EP1530483B1/en not_active Expired - Lifetime
- 2003-06-05 AU AU2003237437A patent/AU2003237437B2/en not_active Ceased
- 2003-06-05 CA CA002485874A patent/CA2485874A1/en not_active Abandoned
- 2003-06-05 MX MXPA04011646A patent/MXPA04011646A/es not_active Application Discontinuation
- 2003-06-05 RU RU2004139045/13A patent/RU2004139045A/ru not_active Application Discontinuation
- 2003-06-05 BR BRPI0311578-0A patent/BR0311578A/pt not_active IP Right Cessation
- 2003-06-05 AT AT03736888T patent/ATE453727T1/de not_active IP Right Cessation
- 2003-06-05 DE DE60330780T patent/DE60330780D1/de not_active Expired - Lifetime
- 2003-06-05 PL PL374723A patent/PL213315B1/pl unknown
- 2003-06-05 CN CNA038186314A patent/CN1674931A/zh active Pending
- 2003-06-05 JP JP2004511467A patent/JP2005528910A/ja not_active Withdrawn
- 2003-06-05 NZ NZ537403A patent/NZ537403A/en not_active IP Right Cessation
- 2003-06-05 WO PCT/US2003/017873 patent/WO2003104407A2/en not_active Ceased
-
2004
- 2004-11-12 NO NO20044945A patent/NO20044945L/no not_active Application Discontinuation
- 2004-11-14 IL IL165194A patent/IL165194A/en not_active IP Right Cessation
- 2004-12-02 ZA ZA200409792A patent/ZA200409792B/en unknown
-
2010
- 2010-04-01 JP JP2010085593A patent/JP2010207226A/ja not_active Withdrawn
- 2010-06-27 IL IL206650A patent/IL206650A/en not_active IP Right Cessation
-
2013
- 2013-03-05 JP JP2013042552A patent/JP2013126420A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL206650A0 (en) | 2011-07-31 |
| BR0311578A (pt) | 2007-04-27 |
| AU2003237437B2 (en) | 2010-11-25 |
| EP1530483B1 (en) | 2009-12-30 |
| ZA200409792B (en) | 2006-07-26 |
| CA2485874A1 (en) | 2003-12-18 |
| WO2003104407A2 (en) | 2003-12-18 |
| JP2013126420A (ja) | 2013-06-27 |
| EP1530483A2 (en) | 2005-05-18 |
| IL165194A0 (en) | 2005-12-18 |
| NO20044945L (no) | 2004-12-28 |
| IL206650A (en) | 2016-10-31 |
| JP2010207226A (ja) | 2010-09-24 |
| CN1674931A (zh) | 2005-09-28 |
| NZ537403A (en) | 2009-10-30 |
| RU2004139045A (ru) | 2005-09-10 |
| PL213315B1 (pl) | 2013-02-28 |
| JP2005528910A (ja) | 2005-09-29 |
| IL165194A (en) | 2010-11-30 |
| PL374723A1 (en) | 2005-10-31 |
| WO2003104407A3 (en) | 2005-03-24 |
| ATE453727T1 (de) | 2010-01-15 |
| EP1530483A4 (en) | 2006-05-17 |
| AU2003237437A1 (en) | 2003-12-22 |
| MXPA04011646A (es) | 2005-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL206650A0 (en) | T cell receptor cdr3 peptide for treating an autoimmune disease | |
| CY1107944T1 (el) | Χρησεις του μπορρελιοκτονου επιτοπου (-ων) της πρωτεϊνης c εξωτερικης επιφανειας borrelia burgdorferi (ospc) σαν εμβολιο | |
| TW200616657A (en) | Therapeutic peptides and method | |
| CY1107146T1 (el) | Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad) | |
| HUP9802212A2 (hu) | Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok | |
| DE69831500D1 (de) | Humane checkpointkinase, hcds1, zusammensetzungen und verfahren | |
| DE69931482D1 (de) | Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen | |
| ATE534669T1 (de) | Verfahren zum erhalten von anti-idiotyp antikörpern | |
| EP2192407A3 (en) | Method of detecting cellular immunity and application thereof to drugs | |
| CY1105380T1 (el) | Προτιμωμενα τμηματα της νευρικης νηματικης πρωτεϊνης και μεθοδοι χρησης αυτων | |
| RU2007115411A (ru) | Пептиды hsp60 и их apl-производные и фармацевтические композиции | |
| DK1523548T3 (da) | Polynukleotidsekvenser, som koder for alkaliske alfa-galactosidaser, og fremgangsmåder til anvendelse heraf | |
| WO2004113566A3 (en) | Disease related protein network | |
| WO2004043397A3 (en) | Compositions and methods for the treatment of rheumatoid arthritis | |
| HUP0301111A2 (hu) | Potenciálisan immundomináns acetilkolin-receptor oligopeptideket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| AU8488401A (en) | Cng2b: a novel human cyclic nucleotide-gated ion channel | |
| ATE391913T1 (de) | Peptidepitope die von krankheitsfördernden cd4+ t lymphocyten erkannt werden | |
| DK1569961T3 (da) | Splice variant af det menneskelige hypofysevæksthormon | |
| AU2003302440A1 (en) | Nucleic acid probes and method for detecting a target nucleic acid sequence comprise two or more cis- located nucleic acid regions | |
| ATE526400T1 (de) | Metalloproteaseproteine | |
| WO2004000882A3 (en) | Proteins | |
| ATE366261T1 (de) | Humane 7-transmembranproteine und dafür codierende polynukleotide | |
| WO2004005331A3 (en) | Peptides derived from pep133 (g1p3, 6-16) | |
| MXPA05012414A (es) | Proteina secretada similar a tnf. | |
| WO2004003011A3 (en) | Nuclear hormone receptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |